MNOV (MediciNova) Accounts Payable: $0.85 Mil (As of Mar. 2026)


MNOV MediciNova Inc MNOV
32 GF Score
Price $1.43
! 2 Warning Signs
View Full Analysis

What is MediciNova Accounts Payable?

MediciNova MNOV +0.70% 32 Accounts Payable is $0.85 Mil as of Mar. 2026. GuruFocus rates MNOV with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

MediciNova's Accounts Payable for the quarter that ended in Mar. 2026 was $0.85 Mil.

MediciNova's quarterly Accounts Payable declined from Sep. 2025 ($0.75 Mil) to Dec. 2025 ($0.63 Mil) but then increased from Dec. 2025 ($0.63 Mil) to Mar. 2026 ($0.85 Mil).

MediciNova's annual Accounts Payable increased from Dec. 2023 ($1.00 Mil) to Dec. 2024 ($1.10 Mil) but then declined from Dec. 2024 ($1.10 Mil) to Dec. 2025 ($0.63 Mil).

MediciNova Accounts Payable Historical Data

* Premium members only.

The historical data trend for MediciNova's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediciNova Accounts Payable Chart

MediciNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.43 1.00 1.10 0.63

MediciNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.57 0.75 0.63 0.85
MNOV
32GF Score
MediciNova Inc MNOV
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediciNova Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.85 Mil mean?
MediciNova (MNOV) has a Accounts Payable of $0.85 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on MediciNova and its competitors.
Is MediciNova's Accounts Payable too high?
MediciNova's current Accounts Payable is $0.85 Mil. Overall, MediciNova has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does MediciNova's Accounts Payable compare to TCRX and PMVP?
MediciNova's Accounts Payable of $0.85 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on MediciNova and its competitors. MediciNova's current Accounts Payable is $0.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediciNova stock overvalued right now?
MediciNova (MNOV) has a current Accounts Payable of $0.85 Mil. The current Accounts Payable is $0.85 Mil. MediciNova's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For MediciNova (MNOV), the current Accounts Payable is $0.85 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MediciNova Business Description

Other Exchanges 4875:Japan
Address 4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
32GF Score

Get the complete analysis for MNOV

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.43
Price